Proteomic profiles of patients with atrial fibrillation provide candidate biomarkers for diagnosis
Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide with an increasing risk of heart failure, stroke, and thromboembolic events. Currently distinct pathophysiological mechanisms during AF development and valuable biomarkers for AF management remain unknown.
Source: International Journal of Cardiology - Category: Cardiology Authors: WeiYi Zhong, Hui Yang, YuLin Wang, Ye Yang, ChangFa Guo, ChunSheng Wang, Qiang Ji Source Type: research
More News: Arrhythmia | Atrial Fibrillation | Cardiac Arrhythmia | Cardiology | Heart | Heart Failure | Stroke